These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32332923)

  • 21. SFPQ and Tau: critical factors contributing to rapid progression of Alzheimer's disease.
    Younas N; Zafar S; Shafiq M; Noor A; Siegert A; Arora AS; Galkin A; Zafar A; Schmitz M; Stadelmann C; Andreoletti O; Ferrer I; Zerr I
    Acta Neuropathol; 2020 Sep; 140(3):317-339. PubMed ID: 32577828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serine/arginine-rich splicing factor 3 (SRSF3) regulates homologous recombination-mediated DNA repair.
    He X; Zhang P
    Mol Cancer; 2015 Aug; 14():158. PubMed ID: 26282282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Emerging Role of the RNA-Binding Protein SFPQ in Neuronal Function and Neurodegeneration.
    Lim YW; James D; Huang J; Lee M
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons and is itself regulated by lysine mono-methylation.
    Carlson SM; Soulette CM; Yang Z; Elias JE; Brooks AN; Gozani O
    J Biol Chem; 2017 Aug; 292(32):13381-13390. PubMed ID: 28655759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serine-arginine splicing factor 2 promotes oesophageal cancer progression by regulating alternative splicing of interferon regulatory factor 3.
    Wei Z; Wang Y; Ma W; Xing W; Lu P; Shang Z; Li F; Li H; Wang Y
    RNA Biol; 2023 Jan; 20(1):359-367. PubMed ID: 37335045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1.
    Wu DD; Li XS; Meng XN; Yan J; Zong ZH
    Tumour Biol; 2016 Aug; 37(8):10499-506. PubMed ID: 26850595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells.
    Moraya AI; Ali JL; Samadder P; Liang L; Morrison LC; Werbowetski-Ogilvie TE; Ogunsina M; Schweizer F; Arthur G; Nachtigal MW
    J Exp Clin Cancer Res; 2017 May; 36(1):67. PubMed ID: 28499442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer.
    Gambelli A; Nespolo A; Rampioni Vinciguerra GL; Pivetta E; Pellarin I; Nicoloso MS; Scapin C; Stefenatti L; Segatto I; Favero A; D'Andrea S; Mucignat MT; Bartoletti M; Lucia E; Schiappacassi M; Spessotto P; Canzonieri V; Giorda G; Puglisi F; Vecchione A; Belletti B; Sonego M; Baldassarre G
    EMBO Mol Med; 2024 May; 16(5):1162-1192. PubMed ID: 38658801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Murine Long Noncoding RNA Morrbid Contributes in the Regulation of NRAS Splicing in Hepatocytes In Vitro.
    Fefilova A; Melnikov P; Prikazchikova T; Abakumova T; Kurochkin I; Mazin PV; Ziganshin R; Sergeeva O; Zatsepin TS
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32764370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.
    Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A
    Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of LRRC8A protects human ovarian and alveolar carcinoma cells against Cisplatin-induced expression of p53, MDM2, p21Waf1/Cip1, and Caspase-9/-3 activation.
    Sørensen BH; Nielsen D; Thorsteinsdottir UA; Hoffmann EK; Lambert IH
    Am J Physiol Cell Physiol; 2016 Jun; 310(11):C857-73. PubMed ID: 26984736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer.
    Samardzija C; Luwor RB; Volchek M; Quinn MA; Findlay JK; Ahmed N
    Mol Cancer; 2015 Aug; 14():152. PubMed ID: 26260289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Snail Driving Alternative Splicing of CD44 by ESRP1 Enhances Invasion and Migration in Epithelial Ovarian Cancer.
    Chen L; Yao Y; Sun L; Zhou J; Miao M; Luo S; Deng G; Li J; Wang J; Tang J
    Cell Physiol Biochem; 2017; 43(6):2489-2504. PubMed ID: 29131012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PACT cessation overcomes ovarian cancer cell chemoresistance to cisplatin by enhancing p53-mediated apoptotic pathway.
    Yang X; Zhang Q; Yang X; Zhao M; Yang T; Yao A; Tian X
    Biochem Biophys Res Commun; 2019 Apr; 511(4):719-724. PubMed ID: 30827507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High claudin-7 expression is associated with a poor response to platinum-based chemotherapy in epithelial ovarian carcinoma.
    Kim CJ; Lee JW; Choi JJ; Choi HY; Park YA; Jeon HK; Sung CO; Song SY; Lee YY; Choi CH; Kim TJ; Lee JH; Kim BG; Bae DS
    Eur J Cancer; 2011 Apr; 47(6):918-25. PubMed ID: 21134740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species.
    Yang YI; Kim JH; Lee KT; Choi JH
    Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-nuclear Pool of Splicing Factor SFPQ Regulates Axonal Transcripts Required for Normal Motor Development.
    Thomas-Jinu S; Gordon PM; Fielding T; Taylor R; Smith BN; Snowden V; Blanc E; Vance C; Topp S; Wong CH; Bielen H; Williams KL; McCann EP; Nicholson GA; Pan-Vazquez A; Fox AH; Bond CS; Talbot WS; Blair IP; Shaw CE; Houart C
    Neuron; 2017 Apr; 94(2):322-336.e5. PubMed ID: 28392072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The RNA-binding protein SFPQ orchestrates an RNA regulon to promote axon viability.
    Cosker KE; Fenstermacher SJ; Pazyra-Murphy MF; Elliott HL; Segal RA
    Nat Neurosci; 2016 May; 19(5):690-696. PubMed ID: 27019013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer.
    Sun J; Cai X; Yung MM; Zhou W; Li J; Zhang Y; Li Z; Liu SS; Cheung ANY; Ngan HYS; Li Y; Dai Z; Kai Y; Tzatsos A; Peng W; Chan DW; Zhu W
    Oncogene; 2019 Jan; 38(4):564-580. PubMed ID: 30166592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Galectin-3 regulates chemotherapy sensitivity in epithelial ovarian carcinoma via regulating mitochondrial function.
    Wang D; You D; Li L
    J Toxicol Sci; 2019; 44(1):47-56. PubMed ID: 30626779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.